NPCE CIK: 1528287

NeuroPace Inc

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
133
FY22:
97.7
FY23:
92.7
FY24:
81.3
FY25:
94.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.75
FY22:
16.4
FY23:
14.9
FY24:
13.3
FY25:
11.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
134
FY22:
114
FY23:
108
FY24:
94.6
FY25:
106

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
9.30
FY22:
11.0
FY23:
16.2
FY24:
15.2
FY25:
17.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
50.8
FY22:
68.4
FY23:
70.8
FY24:
71.5
FY25:
68.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
73.5
FY22:
34.8
FY23:
20.7
FY24:
8.01
FY25:
19.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
134
FY22:
114
FY23:
108
FY24:
94.6
FY25:
106

All amounts in millions USD Data source:SEC EDGAR